NCT03122418

Brief Summary

Approximately half of the variation in the presentation and disease status of patients with Cystic Fibrosis (CF) is secondary to non-genetic variables.\[1\] These include household income, compliance with therapy, second hand smoke exposure and possibly exercise (although exercise has less evidence to support its influence on disease status). Recently increased attention has been focused on the role of exercise and quality of life for patients with CF. This study will evaluate the role of exercise in relation to the patient's perception of their quality of life. The primary outcome will be the overall change in the patient's Cystic Fibrosis Questionnaire - Revised (CFQ-R) over a one year period during which the participants are encouraged to exercise and use a personal fitness device to track their exercise. This is a prospective single group non-blinded study. Participants will be asked to wear a personal fitness device for 11-13 months. The change in CFQ-R score is the primary outcome and other secondary outcomes will include; (1) exacerbations of cystic fibrosis (through use of antibiotics), (2) change in subject's FEV1, (3) inpatient admission rates, (4) change in BMI and (5) change in 6 minute walk test. The study will take place at the Adult CF Clinic on the University of Oklahoma Health Sciences Center campus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable quality-of-life

Timeline
Completed

Started Apr 2017

Typical duration for not_applicable quality-of-life

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2017

Completed
1 day until next milestone

Study Start

First participant enrolled

April 18, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 20, 2017

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2019

Completed
Last Updated

February 15, 2024

Status Verified

February 1, 2024

Enrollment Period

1.8 years

First QC Date

April 17, 2017

Last Update Submit

February 13, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in quality of life for individuals with CF using a personal fitness device

    Will be measured using the CFQ-R questionnaire (a standard questionnaire for CF patients)

    Will be completed upon enrollment and at 6 months and 12 months

Secondary Outcomes (1)

  • Walking distance

    This will be done upon enrollment, 6 months and 12 months

Study Arms (1)

Exercise Study Group

EXPERIMENTAL

All subjects in this study will receive a personal fitness device and be asked to participate in some routine exercise. Each participant will be compared to their own initial CFQ-R score (to measure quality of life) before and after use of the personal fitness device.

Behavioral: Personal Fitness Device

Interventions

Subjects will be given a personal fitness device to use to encourage exercise routinely. The impact this has on the individual perception of their quality of life will be the primary outcome for this study

Exercise Study Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of CF,
  • age of 21 or older,
  • willingness to consider some type of routine exercise,
  • BMI above 18 if female and above 20 for males,
  • willing to wear personal fitness device daily and
  • not already preforming daily exercise routinely

You may not qualify if:

  • patients who are unable or unwilling to understand and sign consent for this study,
  • patients who the study physicians determine it would not be safe to ask them to exercise,
  • patients who are not expected to survive over the next 12 months,
  • patients who are non-compliant and will not comply with study visits and procedures,
  • patients currently participating in other research trials,
  • patients who have had an acute exacerbation of their cystic fibrosis (treatment with oral or IV antibiotics) within the last 30 days,
  • patients with significant room air hypoxia who require more than 4 liters by nasal cannula to improve oxygenation to more than 90%.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, 73104, United States

Location

Study Officials

  • Karen S Allen, MD

    OUHSC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Subjects will receive a personal fitness device and asked to develop an individual exercise program.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2017

First Posted

April 20, 2017

Study Start

April 18, 2017

Primary Completion

February 1, 2019

Study Completion

February 1, 2019

Last Updated

February 15, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Initial data analysis was clear that study completion would not lead to a statistically significant difference in the primary outcome. Data are available and may be obtained through written request to the PI.

Locations